|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review |
 |
Pooled baseline data from all 254 patients.
Responders defined using Proposition A with cut-points for knee oral
NSAIDs.
Outcomes at end of study (26 weeks) compared between responders and
nonresponders. No adjustments
for baseline variables performed.
|